Present Investigation
Plan.-On account of the progressively diminishing number of cases it was not feasible to run a new trial with two concurrent groups. It was therefore decided to reduce the minimum number of intrathecal streptomycin injections from 45 to 25 by giving daily injections for six days, followed by three injections weekly, until a total of 25 injections had been reached by the end of the seventh week of treatment. The total duration of intrathecal treatment remained as in the earlier series. Subsequent similar intrathecal courses were given if -the clinical condition of the patient or the state of the C.S.F. demanded it, according to the criteria outlined in a previous communication (Lorber, 1954a) . In all other respects the treatment remained as in the preceding series (Lorber, 1954b) (Table I) . Dr. Colver's patients continued to receive a minimum of 45 intrathecal injections. to the hospital with tuberculous meningitis, and all were included in the study. They were between 4 months and 13 years of age, three being 12 months old or less. Seventeen patients were conscious on admission, two being particularly early cases, and three were in an advanced stage of the disease. Five had associated miliary tuberculosis. The diagnosis was established by the usual clinical features, a positive tuberculin test, and the characteristic C.S.F. in all cases. Tubercle bacilli were seen in a direct smear of the pre-treatment specimen of C.S.F. in every case, and were subsequently recovered on culture in 16 cases and from inoculated guinea-pigs in 17 cases. In two cases both culture and guinea-pig inoculations were negative.
Treatment No patient required more than the planned minimum period of six months of systemic treatment. The C.S.F. showed a significant deterioration in four children after the completion of a course of 25 intrathecal injections, and in two of these tubercle bacilli reappeared in the C.S.F. during *Based on a paper delivered at the S6minaire sur le Traitement (Fig. A) earlier series. The introduction of regular schooling into the unit has been an important development in the management of children of school age.
C.S.F. Changes In the present series none of the children developed a spinal block. In our total experience with 51 cases treated with isoniazid, only one case has been seen in which a temporary spinal block developed.
The reduction in the total intrathecal treatment has not resulted in any delay in the return of the C.S.F. to norrhal as compared with the previous series, and, if anything, the protein returned to normal one to two months earlier (Table  II) . With our treatment it still takes some six to seven isoniazid became available more than one-third of such patients developed meningitis while on streptomycin treatment. The prognosis in these cases was poor, in spite of early diagnosis with routine lumbar punctures. (Table III) . The only child who died was a girl of 3. She was admitted in the advanced stage, in status epilepticus. She never recovered consciousness, and died within a week of admnission. Eighteen children, including three infants, are well and have no neurological or detectable mental sequelae, although two of these are convalescent from a concurrent tuberculous disease of the vertebrae. Two others have a minor hearing loss which is demonstrable only by audiometry, but both of them attend ordinary school and manage without a hearing-aid. We have no information about their hearing before the meningitis developed. One child had two fits during treatment, and as her electroencephalographic pattern is still abnormal she is being treated with anticonvulsants, alt.hough she has had no fits since her recovery. Routine intelligence tests are being carried out on all survivors, but it is too early to attempt to give final figures of I.Q.s in this group of children. The lowest figure to date is 89. The girl who relapsed and had a second complete course of treatment is an intelligent child. She attends a grammar school and easily holds her own with children of her own age, in spite of over a year's absence from school. Her I.Q. is 122.
One child is a mentally defective hyperkinetic idiot. The condition of this child was fair on admission, but a few hours later he had a prolonged succession of convulsions, from the effects of which he never recovered. He The large majority of workers agree that oral isoniazid should be given in combination with intramuscular streptomycin and that other tuberculostatic drugs-for example, P.A.S.-may be given in addition. Most agree that intrathecal isoniazid is harmless but unnecessary, because adequate concentrations are present in the C.S.F. after oral administration. The major controversy is centred in intrathecal streptomycin treatment. Many have abandoned its use, but others think that it should be used either in all cases or in a selected group. There is no doubt that since the introduction of isoniazid the need for prolonged courses of intrathecal injections has been greatly reduced, but no one knows the best line of treatment.
We have continuously and successfully reduced the number of intrathecal injections from an average of over 100 in those treated with streptomycin alone to 32 in this series, in which isoniazid was used together with streptomycin and P.A.S. We have, however, not discontinued the routine use of intrathecal streptomycin, for the following reasons:
(1) The high survival rate and the good quality of the survivors with the present line of treatment. (2) A significant deterioration in the C.S.F. occurred in 10 patients after the conclusion of one intrathecal course (45 or 25 injections), and in three of these tubercle bacilli reappeared in the C.S.F. while they were receiving 20 mg./kg. of isoniazid daily. These changes were all successfully reversed by further intrathecal treatment. (3) We have been unable to find criteria which would indicate which patients would not require intrathecal treatment, or which patients would need more than one course. Some of the 10 children who had to have more than one course were among the earliest cases, and some advanced cases did well on a single course. (4) It would be undesirable to omit intrathecal treatment and then start it later if the course of the disease were unfavourable, because of the risk of irreversible cerebral changes.
We have not found convincing evidence from the literature that intrathecal streptomycin is unnecessary. There are some who claim a high proportion of survival rates, but these rates are on the whole lower than those obtained with intrathecal treatment. It is not possible to be dogmatic about this, as there has been no report of a properly controlled investigation in which concurrent cases were treated with or without intrathecal streptomycin, while receiving streptomycin systemically together with isoniazid. It is noteworthy, however, that in some series treated without intrathecal injections the number of deaths in the first four weeks of treatment is unduly high. These deaths cannot be regarded as inevitable, as the patients did not have the benefit of intrathecal treatment.
For these reasons it is thought that at present the optimum treatment of tuberculous meningitis should include intrathecal streptomycin therapy, although it might be possible to reduce the number of injections even further. As we cannot foretell which patients will survive without intrathecal treatment, it is preferable to give it to some of them unnecessarily rather than to withhold it from those who need it.
Use of Cortisone
We have no experience with cortisone or corticotrophin as adjuncts in the treatment of tuberculous meningitis. It is claimed that these drugs are useful in the prevention of obstructions in the C.S.F. pathways. There has not been, however, a single paper describing a controlled study of the value of cortisone. This does not mean that cortisone may not be of benefit in some cases or that it may not replace the intrathecal use of tuberculin. It must be borne in mind, however, that obstructions in the C.S.F. pathways very rarely develop with modern treatment. Only one case with a temporary spinal block has been seen in the 51 cases treated with isoniazid. Astonishing recoveries can occur from apparently hopeless situations without the use of cortisone, and such occurrences need not be attributed to cortisone treatment.
Effects of Earlier Diagnosis
Of the 69 consecutive unselected patients who were treated in the Children's Hospital, Sheffield, during 1952-4 inclusive, 59 (85.5 %) are alive (Table IV) . These figures include those In 1870 Wilks pointed out that bacterial endocarditis may exist "even though we fail to detect any morbid sounds in the heart." The cases which he mentioned had neither signs nor history of a " primary heart affection," and several of them were examples of acute bacterial endocarditis. Rarely, subacute bacterial endocarditis also occurs in patients with no detectable heart disease, when, for instance, the infection involves a bicuspid aortic valve. To diagnose these cases before a murmur appears is obviously difficult, but it is particularly desirable, since prompt treatment could prevent them from developing valve lesions. In this paper the histories of four patients in whom bacterial endocarditis was at first murmurless are reviewed in an attempt to discover how the disease may be diagnosed before the valves become damaged. In two cases the condition was suspected and treatment was started before a murmur appeared, but in neither of them soon enough to avert valve damage. Case 1. Acute Bacterial Endocarditis In 1948 a 39-year-old policeman developed sudden fever, with severe malaise and headache. He had no symptoms of a respiratory infection, no joint pains, and no history of previous rheumatic fever. On treatment with salicylates he failed to improve, and later began to have rigors. When admitted to hospital after two weeks' illness, he was pale and sweating profusely (temperature 103 F.-39.4' C.) but no abnormal signs were found apart from tachycardia. The haemoglobin was 68%, the white blood count 9,800, and
